incobotulinumtoxinA

CHEBI:CHEBI_748525

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1732165
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
pharm_class_pe
Neuromuscular Blockade [PE]
pharm_class
Acetylcholine Release Inhibitors [MoA]
marketing_category
BLA
active_ingredient_name
BOTULINUM TOXIN TYPE A
active_ingredient_strength
200 [USP'U]/1
unii
E211KPY694
nui
N0000175770
pharm_class_epc
Neuromuscular Blocker [EPC]
pharm_class_moa
Acetylcholine Release Inhibitors [MoA]
marketing_start_date
20151120
package_marketing_start_date
20151120
generic_name
incobotulinumtoxinA
brand_name
Xeomin
brand_name_base
Xeomin
product_ndc
46783-161
application_number
BLA125360
labeler_name
Merz Pharmaceuticals, LLC
manufacturer_name
Merz Pharmaceuticals, LLC
spl_id
4b565d1a-8324-49e9-8c03-7af08631bbde
package_ndc
46783-161-01
package_description
1 VIAL, SINGLE-USE in 1 CARTON (46783-161-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
spl_set_id
ccdc3aae-6e2d-4cd0-a51c-8375bfee9458
upc
0346783161010
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class